Friday, April 28, 2023

Management of Tenofovir Induced Osteopenia and Hyperparathyroidism

Help with Treatment: A 48-year-old postmenopausal woman with bone and joint pain was misdiagnosed as having normocalcemic primary hyperparathyroidism
MedSynapse Community of Doctors MedSynapse
Management of Tenofovir Induced Osteopenia and Hyperparathyroidism

A 48-year-old postmenopausal woman with bone and joint pain was misdiagnosed as having normocalcemic primary hyperparathyroidism but was later found to have osteoporosis and secondary hyperparathyroidism caused by prolonged exposure to tenofovir disoproxil fumarate.

The levels of calcium and phosphorus excreted in urine over a 24-hour period were within the normal range but towards the lower end. For the past 9 years, she has been undergoing extended medical care to manage her condition of chronic hepatitis B caused by a viral infection. 

Quick options for you (click to select) :
What are the treatments used for the osteopenia and hyperparathyroidism in this patient?
Teriparatide
Vitamin B3
Bisphosphonates
Denosumab
Suggest Treatment
This email is intended for Dr. Renukaprasad A R Unsubscribe / Change your email preferences.

© 2023 MedSynapse, USA, Singapore, India, Dubai

No comments:

Post a Comment